Perspectives on introduction and implementation of new point-of-care diagnostic tests

Kara M. Palamountain; Jeff Baker; Elliot P. Cowan; Shaffiq Essajee; Laura T. Mazzola; Mutsumi Metzler; Marco Schito; Wendy S. Stevens; Gloria J. Young; Gonzalo J. Domingo

doi:10.1093/infdis/jis203

Perspectives on introduction and implementation of new point-of-care diagnostic tests

Kara M. Palamountain, Jeff Baker, Elliot P. Cowan, Shaffiq Essajee, Laura T. Mazzola, Mutsumi Metzler, Marco Schito, Wendy S. Stevens, Gloria J. Young, Gonzalo J. Domingo^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

57 Scopus citations

Abstract

In recent years, there has been significant investment from both the private and public sectors in the development of diagnostic technologies to meet the need for human immunodeficiency virus (HIV) and tuberculosis testing in low-resource settings. Future investments should ensure that the most appropriate technologies are adopted in settings where they will have a sustainable impact. Achieving these aims requires the involvement of many stakeholders, as their needs, operational constraints, and priorities are often distinct. Here, we discuss these considerations from different perspectives representing those of various stakeholders involved in the development, introduction, and implementation of diagnostic tests. We also discuss some opportunities to address these considerations.

Original language	English (US)
Pages (from-to)	S181-S190
Journal	Journal of Infectious Diseases
Volume	205
Issue number	SUPPL. 2
DOIs	https://doi.org/10.1093/infdis/jis203
State	Published - May 15 2012

ASJC Scopus subject areas

Infectious Diseases
Immunology and Allergy

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1093/infdis/jis203

Cite this

@article{dfa76fba5e5e4b29bf82e4a25e4929bf,

title = "Perspectives on introduction and implementation of new point-of-care diagnostic tests",

abstract = "In recent years, there has been significant investment from both the private and public sectors in the development of diagnostic technologies to meet the need for human immunodeficiency virus (HIV) and tuberculosis testing in low-resource settings. Future investments should ensure that the most appropriate technologies are adopted in settings where they will have a sustainable impact. Achieving these aims requires the involvement of many stakeholders, as their needs, operational constraints, and priorities are often distinct. Here, we discuss these considerations from different perspectives representing those of various stakeholders involved in the development, introduction, and implementation of diagnostic tests. We also discuss some opportunities to address these considerations.",

author = "Palamountain, {Kara M.} and Jeff Baker and Cowan, {Elliot P.} and Shaffiq Essajee and Mazzola, {Laura T.} and Mutsumi Metzler and Marco Schito and Stevens, {Wendy S.} and Young, {Gloria J.} and Domingo, {Gonzalo J.}",

note = "Funding Information: Financial support. This work was supported by the National Institute of Allergy and Infectious Diseases, US National Institutes of Health (NIH), and the US Department of Health and Human Services (contract HHSN272200800014C). Preparation of the manuscript was funded in part by the National Institute of Biomedical Imaging and Bioengineering, NIH (grant 1U54EB007949-01).",

year = "2012",

month = may,

day = "15",

doi = "10.1093/infdis/jis203",

language = "English (US)",

volume = "205",

pages = "S181--S190",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "SUPPL. 2",

}

TY - JOUR

T1 - Perspectives on introduction and implementation of new point-of-care diagnostic tests

AU - Palamountain, Kara M.

AU - Baker, Jeff

AU - Cowan, Elliot P.

AU - Essajee, Shaffiq

AU - Mazzola, Laura T.

AU - Metzler, Mutsumi

AU - Schito, Marco

AU - Stevens, Wendy S.

AU - Young, Gloria J.

AU - Domingo, Gonzalo J.

N1 - Funding Information: Financial support. This work was supported by the National Institute of Allergy and Infectious Diseases, US National Institutes of Health (NIH), and the US Department of Health and Human Services (contract HHSN272200800014C). Preparation of the manuscript was funded in part by the National Institute of Biomedical Imaging and Bioengineering, NIH (grant 1U54EB007949-01).

PY - 2012/5/15

Y1 - 2012/5/15

N2 - In recent years, there has been significant investment from both the private and public sectors in the development of diagnostic technologies to meet the need for human immunodeficiency virus (HIV) and tuberculosis testing in low-resource settings. Future investments should ensure that the most appropriate technologies are adopted in settings where they will have a sustainable impact. Achieving these aims requires the involvement of many stakeholders, as their needs, operational constraints, and priorities are often distinct. Here, we discuss these considerations from different perspectives representing those of various stakeholders involved in the development, introduction, and implementation of diagnostic tests. We also discuss some opportunities to address these considerations.

AB - In recent years, there has been significant investment from both the private and public sectors in the development of diagnostic technologies to meet the need for human immunodeficiency virus (HIV) and tuberculosis testing in low-resource settings. Future investments should ensure that the most appropriate technologies are adopted in settings where they will have a sustainable impact. Achieving these aims requires the involvement of many stakeholders, as their needs, operational constraints, and priorities are often distinct. Here, we discuss these considerations from different perspectives representing those of various stakeholders involved in the development, introduction, and implementation of diagnostic tests. We also discuss some opportunities to address these considerations.

UR - http://www.scopus.com/inward/record.url?scp=84860364329&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860364329&partnerID=8YFLogxK

U2 - 10.1093/infdis/jis203

DO - 10.1093/infdis/jis203

M3 - Review article

C2 - 22402038

AN - SCOPUS:84860364329

SN - 0022-1899

VL - 205

SP - S181-S190

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - SUPPL. 2

ER -

Perspectives on introduction and implementation of new point-of-care diagnostic tests

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this